Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer

Open access
Kim, Hye Ryun, Kim, Dae Joon, Kang, Dae Ryong, Lee, Jin Gu, Lim, Sun Min, Lee, Chang Young, Rha, Sun Young, Bae, Mi Kyung, Lee, Young Joo, Kim, Se Hoon, Ha, Sang-Jun, Soo, Ross Andrew, Chung, Kyung Young, Kim, Joo Hang, Lee, Ji Hyun, Shim, Hyo Sup, Cho, Byoung Chul · 2013 · Journal of Clinical Oncology

Abstract

Purpose: To investigate the frequency and the prognostic role of fibroblast growth factor receptor 1 (FGFR1) amplification in patients with surgically resected squamous cell carcinoma of the lung (SCCL) and the association between smoking and FGFR1 amplification. Patients and Methods: Gene copy number of FGFR1 was investigated in microarrayed tumors from 262 patients with SCCL who had tumor tissue as well as smoking and survival data available. Gene copy number was evaluated by fluorescent in situ hybridization, and an FGFR1-amplified tumor (FGFR1 amp+) was prespecified as a tumor with nine or more copies of FGFR1. Results: Among 262 patients, the frequency of FGFR1 amp+ was 13.0%. Patients with FGFR1 amp+ had significantly shorter disease-free survival (DFS; 26.9 v 94.6 months; P < .001) as well as shorter overall survival (OS; 51.2 v 115.0 months; P = .002) than those without FGFR1 amp+. Multivariate modeling confirmed that patients with FGFR1 amp+ had a significantly greater risk of recurrence and death than those without FGFR1 amp+ after adjusting for sex, smoking status, pathologic stage, and adjuvant chemotherapy (DFS: adjusted hazard ratio [AHR], 2.24; 95% CI, 1.45 to 3.45; P < .001; OS: AHR, 1.83; 95% CI, 1.15 to 2.89; P = .01). The frequency of FGFR1 amp+ was significantly higher in current smokers than in former smokers and never-smokers (28.9% v 2.5% v 0%; P trend < .001). As the smoking dosage increased, so did the incidence of FGFR1 amp+ (P trend = .002). Conclusion: FGFR1 amplification is an independent negative prognostic factor in surgically resected SCCL and is associated with cigarette smoking in a dose-dependent manner. FGFR1 amplification is a relevant therapeutic target in Asian patients with SCCL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2012.43.8622

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Kim, H. R., Kim, D. J., Kang, D. R., Lee, J. G., Lim, S. M., Lee, C. Y., Rha, S. Y., Bae, M. K., Lee, Y. J., Kim, S. H., Ha, S.-J., Soo, R. A., Chung, K. Y., Kim, J. H., Lee, J. H., Shim, H. S., & Cho, B. C.
Venue
Journal of Clinical Oncology
Published
2013-02-20
Volume
31
Issue
6
Pages
731-737
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2153089464
Cited by
170
References
3
FWCI
18.74
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.